Selling And Administration Expenses 변화 날짜
AbbVie USD 3.61B 273M 2023-12
Abbott USD 2.69B 10M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eisai JPY 92.79B 6.7B 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
J&J USD 5.81B 410M 2023-12
Merck USD 2.75B 272M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pacira USD 65.8M 2.15M 2023-12
Perrigo USD 304M 28.3M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Revance Therapeutics USD 67.73M 8.62M 2023-09
Roche Holding CHF 6.51B 26M 2023-06
UCB EUR 857M 12M 2023-06
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
United Therapeutics USD 128.6M 1000K 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09
Zoetis USD 565M 40M 2023-12



AbbVie 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2024.